Gyre Therapeutics (GYRE) Revenue (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.46% |
| Dec 31, 2025 | 21.70% |
| Sep 30, 2025 | 14.17% |
| Jun 30, 2025 | 21.37% |
| Mar 31, 2025 | -20.86% |
| Dec 31, 2024 | 9.35% |
| Sep 30, 2024 | 1.04% |
| Jun 30, 2024 | -7.17% |
| Mar 31, 2024 | 0.09% |
| Dec 31, 2023 | -15.27% |
| Sep 30, 2023 | 9.25% |
| Jun 30, 2023 | 17.64% |
| Mar 31, 2023 | -75.44% |
| Mar 31, 2022 | -67.46% |
| Dec 31, 2021 | 6.13% |
| Sep 30, 2021 | 103.09% |
| Jun 30, 2021 | -22.84% |
| Mar 31, 2021 | -27.77% |
| Dec 31, 2020 | 127.44% |
| Sep 30, 2020 | -46.14% |
| Jun 30, 2020 | -89.87% |
| Mar 31, 2018 | -98.11% |
| Dec 31, 2017 | 0.00% |
| Sep 30, 2017 | 186.49% |
| Jun 30, 2017 | -59.04% |
| Mar 31, 2017 | 281.69% |
| Dec 31, 2016 | -34.86% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | -87.31% |
| Jun 30, 2015 | 27.83% |
| Mar 31, 2015 | 0.00% |
| Dec 31, 2014 | 22.85% |
| Sep 30, 2014 | 84.18% |
| Jun 30, 2014 | 0.00% |
| Mar 31, 2014 | 219.35% |
| Mar 31, 2013 | 499.32% |
| Dec 31, 2012 | -23.18% |
| Sep 30, 2012 | -97.72% |
| Jun 30, 2012 | 47.20% |
| Mar 31, 2012 | 20.65% |
| Dec 31, 2011 | -0.05% |
| Sep 30, 2011 | -8.62% |
| Jun 30, 2011 | -46.80% |
| Mar 31, 2011 | 77.85% |
| Dec 31, 2010 | 16,021.32% |
| Sep 30, 2010 | -31.31% |